Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
23andMe.v2 (USA, Europe) C self-reported clinical diagnosis O 3261 (39%) 29499 (42%) 64 (11) - - - 49 (15) - 9,752
23andMe.v3 (USA, Europe) C self-reported clinical diagnosis O 866 (39%) 32538 (40%) 64 (11) - - - 44 (16) - 9,852
France (IPDGC) C UKPDSBB CL 985 (41%) 1984 (33%) 49 (13) - - - 74 (5) - 9,821
France (NeuroX) C not provided CL 553 474 - - - - - - 27
Germany (IPDGC) C UKPDSBB CL, PO 667 (40%) 937 (48%) 56 (12) - - - 47 (12) - 9,646
Germany (NeuroX) C not provided CL 1,044 871 - - - - - - 27
Greece (NeuroX) C not provided CL 944 877 - - - - - - 27
Iceland (IPDGC-deCODE) C UKPDSBB CL 604 (48%) 4916 (57%) 62 (12) - - - 80 (8) - 9,406
Iceland (CHARGE-AGES-RS) C ICD codes, medication PO 146 (55%) 5609 (59%) 75 (8) - - - 69 (9) - 8,205
Netherlands (IPDGC) C UKPDSBB CL, PO 744 (36%) 2019 (64%) 56 (12) - - - 56 (6) - 9,595
Netherlands (NeuroX) C not provided CL 97 247 - - - - - - 27
UK (IPDGC) C UKPDSBB CL, PO 1705 (43%) 5200 (50%) 64 (12) - - - 53 (0) - 9,673
UK (NeuroX) C not provided CL 405 547 - - - - - - 27
USA (IPDGC-NIA) C UKPDSBB CL 937 (40%) 1896 (53%) 58 (13) - - - 63 (10) - 9,622
USA (Ashkenazi) C UKPDSBB CL 268 (33%) 178 (57%) 60 (12) - - - 70 (9) - 9,631
USA (HIHG) C UKPDSBB CL 574 (37%) 619 (65%) 57 (12) - - - 69 (10) - 9,723
USA (NGRC) C UKPDSBB CL 1956 (33%) 1982 (61%) 59 (12) - - - 70 (14) - 9,938
USA (PROGENI-GenePD) C UKPDSBB CL 828 (40%) 852 (60%) 62 (11) - - - 55 (13) - 9,762
USA (CHARGE-CHS) C self-report, ICD-9, medications PO 107 (45%) 3164 (61%) 73 (5) - - - 72 (5) - 9,655
USA (CHARGE-FHS) C UKPDSBB PO 60 (42%) 3889 (55%) 76 (11) - - - 64 (12) - 9,223
USA (NeuroX) C not provided CL 2,407 2,782 - - - - - - 27

Polymorphisms in this study [+]